CANDISS ASCHENBRENNER: Open Payments
NPI 1518543768 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 34 payments from 16 companies in 2025. Trend: 2023 $192 · 2024 $235 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 15 | $220 |
| QOL Medical, LLC | 2 | $62 |
| PFIZER INC. | 1 | $54 |
| Tempus AI, Inc | 1 | $53 |
| Janssen Biotech, Inc. | 2 | $42 |
| Ardelyx, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: ZENPEP, Sucraid, VELSIPITY, XT CDX, RYBREVANT, IBSRELA, VOQUEZNA, VOWST.
Industry payments across ID — which companies pay providers there.
